In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis

The host defense derived peptide was assessed in different model systems with increasing complexity employing the highly aggressive NRAS mutated melanoma metastases cell line MUG-Mel2. Amongst others, fluorescence microscopy and spectroscopy, as well as cell death studies were applied for liposomal,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wußmann, Maximiliane, Groeber-Becker, Florian Kai, Riedl, Sabrina, Alihodzic, Dina, Padaric, Daniel, Gerlitz, Lisa, Stallinger, Alexander, Liegl-Atzwanger, Bernadette, Zweytick, Dagmar, Rinner, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687695/
https://www.ncbi.nlm.nih.gov/pubmed/36428530
http://dx.doi.org/10.3390/biomedicines10112961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687695/
https://www.ncbi.nlm.nih.gov/pubmed/36428530
http://dx.doi.org/10.3390/biomedicines10112961

Ejemplares similares